Your browser version may not work well with NCBI's Web applications. More information here...
1: Hematology. 2003 Apr;8(2):105-13.Click here to read Links

Acute promyelocytic leukemia: a case-based review.

Gupta V, Tabak D, Keating A.

Department of Medical Oncology and Hematology, Princess Margaret Hospital, University of Toronto, Toronto, Canada; M5G 2M9. vikas.gupta@uhn.on.ca

Retinoid therapy for acute promyelocytic leukemia (APL) is one of the major achievements of leukemia research in the last 15 years. Use of all trans retinoic acid (ATRA) has changed the prognosis of APL from a fatal leukemia to a highly curable disease. This case-based review examines the available clinical and scientific data to form evidence-based decisions in the management of APL. The main aim of this review is to highlight recent progress made in the management of APL and address the role of maintenance therapy, prognostic factors for relapse and treatment of relapsed disease.

PMID: 12745660 [PubMed - indexed for MEDLINE]

Patient Drug Information

  • Daunorubicin (Cerubidine® , DaunoXome® )

    Your doctor has ordered the drug daunorubicin to help treat your illness. The drug is given by injection into a vein.

  • Methotrexate (Rheumatrex® , Trexall® )

    Methotrexate is used to treat severe psoriasis (a skin disease in which red, scaly patches form on some areas of the body) that cannot be controlled by other treatments. Methotrexate is also used along with rest, physica...

  • Tretinoin (Vesanoid® )

    Tretinoin is used to treat acute promyelocytic leukemia (APL; a type of cancer in which there are too many immature blood cells in the blood and bone marrow) in people who have not been helped by other types of chemother...

  • » See all 4 drug reports ...
  • Source: AHFS Consumer Medication Information